/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

ARQT — Arcutis Biotherapeutics, Inc. Common Stock

Nasdaq

Arcutis Biotherapeutics, Inc. Common Stock

Back to Screener
$25.16
-0.13(-0.51%)
O
25.64
H
25.78
L
25.01
V
1.78M
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Arcutis Biotherapeutics, Inc. Common Stock Statistics

Total Valuation

Market Cap$3.38B
Enterprise Value$3.36B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding125.69M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio167.73
P/TBV Ration/a
P/FCF Ratio1,511.22
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-297.44
EV / Salesn/a
EV / EBITDA-535.64
EV / EBIT-491.59
EV / FCF1,500.46

Financial Position

Current Ratio2.68
Quick Ration/a
Debt / Equity0.56
Debt / EBITDA-1.70
Debt / FCF4.77
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-59.56%
Return on Assets (ROA)-24.55%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-31,907
Employee Count354
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$93.00K
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+18.40%
50-Day Moving Average$25.69
200-Day Moving Average$25.21
Relative Strength Index (RSI)53.73
Average Volume (20 Days)3,547,909

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$95.61M
Operating Income-$9.09M
Pretax Income-$11.20M
Net Income-$11.29M
EBITDA-$6.27M
EBIT-$6.83M
Loss Per Share$-0.09

Balance Sheet

Cash & Cash Equivalents$34.76M
Total Debt$10.67M
Net Cash$24.09M
Net Cash Per Share$0.19
Equity (Book Value)$18.96M
Book Value Per Share$0.15
Working Capital$27.49M

Cash Flow

Operating Cash Flow-$6.62M
Capital Expenditures$0
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$2.24M
FCF Per Share$0.02

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield0.07%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a